Articles related to BLEEDING/BLOOD DISORDERS

The study underscores the potential of dual antiplatelet therapy in reducing the risk of recurrent stroke. However, it also highlights the need for careful patient selection due to the slightly increased risk of moderate-to-severe bleeding.

In a recent breakthrough study, thalidomide has been shown to significantly reduce recurrent bleeding in patients with small-intestinal angiodysplasia. This could pave the way for more effective treatments in the future.

The study’s findings suggest a potential paradigm shift in the management of cancer patients with isolated distal DVT. With the 12-month edoxaban regimen reducing the occurrence of the primary composite endpoint to just 1.0% compared to 7.2% in the three-month group, this could represent a significant advancement in patient care.

New findings suggest that faster sodium correction rates in severe hyponatremia may improve patient outcomes, including lower mortality and shorter hospital stays.

Gain actionable insights into the diagnosis and management of nonmalignant blood disorders at Mayo Clinic’s Classical Hematology 2023 conference. Elevate your practice with evidence-based strategies from leading experts.

The use of reticulocyte hemoglobin content (CHr) presents a significant advancement in diagnosing iron-deficiency anemia. CHr’s potential in early detection, differentiation of hematologic conditions, and real-time assessment could pave the way for more precise and timely patient care.